PubMed Health⌕ Search

Biomedical subjects

X Barreau

Publications and source records attributed to X Barreau.

5 recordsLinked to original sources
PubMed2006

[Facial paralysis after temporal bone trauma].

OBJECTIVES: To evaluate functional outcome in 64 cases of facial paralysis following temporal bone fracture and discuss decisive arguments leading either to medical treatment or surgical management. METHODS: Sixty-four patients suffering from post-traumatic facial paralysis were managed between 1995 and 2003: 38 (59%) were given medical treatment and 26 (41%) underwent surgery. A combined middle fossa and transmastoid approach was mostly used (58%). Electrophysiological testing and CT scan results were the main points of the decision algorithm. RESULTS: Electroneuromyography seems to be the most accurate exploration for guiding treatment. Good results (grades I to II on the House and Brackmann scale) were obtained in 63% of cases after medical management and in 39% of cases after surgical treatment. Grades III or IV were obtained in 13% of medically-treated patients and 42% of surgically-treated patients. CONCLUSION: Management of facial paralysis following temporal bone fracture in accordance with electrophysiological testing (evoked EMG) together with CT scan findings enabled accurate indications for surgical treatment. A good grade I or II result can be expected after medical management. A grade III is at best reached after nerve anastomosis.

Adolescent↗
PubMed2005

[Long term clinical follow up of vertebral hemangiomas treated by percutaneous vertebroplasty].

PURPOSE: Long term clinical follow up of vertebral hemangiomas (VH) treated by percutaneous vertebroplasty. PATIENTS AND METHODS: A retrospective analysis of 19 patients treated fro 21 VH associated with chronic pain in 16 cases, using pecutaneous vertebrosplasty. One patient underwent both vertebroplasty and surgery. Long term follow up (mean 38.6 months; 16-83 months) consisted in the evaluation of residual or secondary pain, its impact on daily activities (using the Oswestry Low Back Pain scale) and the need for pain medication. RESULTS: Long term follow up found 56.2% of patients to be asymptomatic (9/16) and 31.2% (5/16) with occasional pain without much impact on daily activities and no need for chronic use of pain medication. The treatment was ineffective in 2 cases. Three patients treated for aggressive hemangiomas remained painless. There was no complication due to the treatment. No poor outcome was noted. CONCLUSION: Percutaneous vertebroplasty appears to be an effective technique in the treatment of VH with approximately 90% of satisfactory results in the short or long term period.

Adolescent↗
PubMed2004

A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.

A two-centre intra-individual crossover study was performed in 23 patients with suspected high-grade glioma or metastases to assess and compare the safety and enhancement characteristics of two different MRI contrast media (gadobenate dimeglumine, Gd-BOPTA and gadoterate meglumine, Gd-DOTA) at equivalent doses of 0.1 mmol/kg body weight. T1-weighted spin-echo (SE) and T2-weighted fast SE images were obtained before and T1-weighted images 0, 2, 4, 6, 8 and 15 min after injection. T1-weighted images with magnetisation transfer contrast were acquired 12 min after injection. Qualitative assessment by blinded, off-site readers (reader 1:19 patients; reader 2:21) and on-site investigators (23) revealed significant (P< or =0.005) overall preference for Gd-BOPTA over Gd-DOTA for contrast enhancement (Gd-BOPTA preferred in 18, 15 and 18 cases; Gd-DOTA in 0, 1 and 1 and no preference in 1, 5 and 4; off-site readers 1 and 2, and on-site investigators, respectively). A similar significant preference for Gd-BOPTA was expressed by off-site readers and on-site investigators for lesion-to-brain contrast, lesion delineation, internal lesion structure, and overall image preference. Quantitative assessment by off-site readers revealed significantly (p<0.05) greater lesion enhancement with Gd-BOPTA than with Gd-DOTA at all times from 2 min after injection.

Aged↗